Behavioral surveillance survey (BSS) among injection drug users (IDUs) in Zanjan-Iran

Journal of Zanjan University of Medical Sciences and Health Services

Volumn 19, Issue 74, 2011, Pages 11-

  Shoghli, A R ^a   Mosavi Nasab, S N ^a   Fallahnezhad, M ^b   Momtazi, S ^c,d   Tavasoli, Shirvan S ^e   Haji, Karim B ^f  

^a ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Razi Science Researchers Institute   (Iran)

^c ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Substance Abuse Prevention and Treatment Office (SAPTO)   (Iran)

^e Legal Medicine Organization   (Iran)

^f ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Behavioral surveillance surveys (BSS); High risk behaviours; HIV AIDS; Injection drug users (IDUs)

Indexed keywords

CANNABIS; DIAMORPHINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CROSS-SECTIONAL STUDY; FAMILY HEALTH BEHAVIORAL SURVEILLANCE SURVEY; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; IRAN; MAJOR CLINICAL STUDY; QUESTIONNAIRE; VIRUS TRANSMISSION;

EID: 79953229214     PISSN: 16069366     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Razzaghi EM, Rahimi Movaghar A, Green TC, Khoshnood K. Profiles of risk: a qualitative study of injecting drug users in Tehran, Iran. Harm Reduct J 2006; 3: 12-25.
2. Rahimi Movaghar A, Mohammad K, Razzaghi EM. Trend of drug abuse situation in Iran: a three decade survey. Hakim Res J. 2002; 5: 171-81.
3. Wodak A, Ali R, Farrell M. HIV in Injecting drug users in Asian countries. Editorial. BMJ 2004; 329: 697-8.
4. Tait R. "Iran faces up to its most lethal threat-drugs". The Guardian. 2005. [cited 2005 Oct 27]. Available from URL: http://www.guardian.co.uk/world/2005/oct/27/iran.roberttait
5. Ministry of Health and Medical Education, Centre for Diseases Management, Latest statistics about HIV infection in the Islamic Republic of Iran. 2009. Available from URL: http://www.mums.ac.ir/shares/aids/bahrainis4/PDF/AIDS88_2.pdf
6. Singer M, Stopka T, Siano C, et al. The social geography of AIDS and hepatitis risk: qualitative approaches for assessing local differences in sterile-syringe access among injection drug users. Am J Public Health. 2000; 90: 1049-56.
7. Gollub EL, Rey D, Obadia Y, Moatti JP. Gender differences in risk behaviors among HIV+ persons with an IDU history. The link between partner characteristics and women's higher drugsex risks. The Manif 2000 Study Group. Sex Transm Dis. 1998; 25: 483-8.
8. Poundstone KE, Strathdee SA, Celentano DD. The social epidemiology of Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome. Epidemiol Rev. 2004; 26: 22-35.
9. Friedman SR. Promising social network research results and suggestions for a research agenda. NIDA Res Monogr. 1995; 151: 196-215.
10. Latkin CA, Sherman S, Knowlton A. HIV prevention among drug users: outcome of anetwork-oriented peer outreach intervention. Health Psychol. 2003; 22: 332-9.
11. Trotter RT, Bowen AM, Potter JM. Network models for HIV outreach and prevention programs for drug users. NIDA Res Monogr. 1995; 151: 144-80.
12. Amon J, Brown T, Hogle J, et al. Behavioral Surveillance Surveys (BSS): Guidelines for Repeated Behavioral Surveys in Populations at Risk of HIV. Family Health International, 2000. Available from URL: http://www.who.int/hiv/strategic/en/bss_fhi2000.pdf
13. Zamani S, Kihara M, Gouya MM, et al. High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. J Acquir Immune Defic Syndr. 2006; 42: 342-6.
14. Zamani S, Kihara M, Gouya MM, et al. Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran. AIDS. 2005; 19: 709-16.
15. Razzaghi EM, Rahimi A, Hosseini M, Madani S, Chatterjee A. Rapid situation assessment (RSA) of drug abuse in Iran. Prevention Department, State Welfare Organization, Ministry of Health, I.R. of Iran and United Nations International Drug Control Program. 1998-1999. Available from URL: www.unodc.org/pdf/iran/publications/RSA2000SUMMARY.pdf
16. Narenjiha H, Rafiey H, Baghestani AH, et al. Rapid Situation Assessment of Drug Abuse and Drug Dependence in Iran (2004). Dariush Institute of Education and Research of Substance Abuse (In Farsi, not published).
17. Khani M, Vakili MM. Prevalence and risk factors of HIV, hepatitis B virus and hepatitis C virus infections in drug addicts among Zanjan prisoners. Arch Iranian Med. 2003; 6: 1-4.
18. Day C, Nassirimanesh B, Shakeshaft A, Dolan K. Patterns of drug use among a sample of drug users and injecting drug users attending a General Practice in Iran. Harm Reduct J. 2006; 3: 2.
19. Zamani S, Vazirian M, Nassirimanesh B, et al. Needle and syringe sharing practices among injecting drug users in Tehran: a comparison of two neighborhoods, one with and one without a needle and syringe program. AIDS Behav. 2008; 16: 10.1007/s10461-008-9404-2.
20. Rowhani Rahbar A, Rooholamini S, Khoshnood K. Prevalence of HIV infection and other blood-borne infections in incarcerated and non-incarcerated injection drug users (IDUs) in Mashhad, Iran. Int J Drug Policy. 2004; 15: 151-5.
21. Islamic Republic of Iran Country Report on Monitoring of the United Nations General Assembly Special Session on HIV and AIDS. Office of the Under-secretary for Health, Ministry of Health and Medical Education, Centre for Diseases Management. 2006. Available from URL: http://www.behdasht.gov.ir/uploads/Iran%20UNGASS%20report%202008%20ver14%20Persian_9179.pdf
22. Vazirian M, Nassirimanesh B, Zamani S, et al. Needle and syringe sharing practices of injectingdrug users participating in an outreach HIV prevention program in Tehran, Iran: A crosssectional study. Harm Reduct J. 2005; 2: 19.
23. Mohammadi MR, Mohammad K, Khalaj Abadi Farahani F, et al. Reproductive knowledge, attitudes and behavior among adolescent males in Tehran, Iran. Int Fam Plan Perspect. 2006; 32: 35-44.
24. Khodabandeh G, Fakhireh F, Naserinia MR, Foladi S. Prevalence of high-risk sexual behavior in drug users referred to the counseling center. Second Congress of High Risk Behaviors. 2007. Zahedan, Iran.
25. Mokri A. Brief overview of the status of drug abuse in Iran. Arch Iranian Med. 2002; 5: 184-90.